PB1297 A UK Single Centre Experience of Switching Adolescents with Severe Haemophilia A to Turoctocog Alfa Pegol

Certolizumab pegol
DOI: 10.1016/j.rpth.2023.101099 Publication Date: 2023-11-11T01:16:38Z